Aurobindo Pharma reported INR16.03B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Cipla INR 17.78B 2.41B Jun/2025
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Dr.Reddys Laboratories INR 21.74B 989M Jun/2025
Hindustan Unilever INR 37.18B 710M Jun/2025
Sun Pharmaceuticals INR 39.48B 5.23B Jun/2025
UPL INR 12.77B 19.6B Jun/2025